Will I Get a Placebo? The Honest Answer

The short answer is: it depends entirely on the trial design. Some trials use placebos; many don't. And even in trials that do use them, there are important rules about when and how they can be used.

Why placebos exist in trials

A placebo-controlled trial is designed to isolate whether a treatment works beyond the placebo effect itself. The placebo effect is real — people who believe they're receiving treatment often show measurable improvement even when they're not. To know whether a treatment actually works, researchers need a comparison group that receives the same experience (visits, procedures, tablets, infusions) but without the active compound.

This isn't a trick. It's how we generate trustworthy evidence. Without placebo controls, it's much harder to know whether a treatment is genuinely effective or whether patients improved because they expected to.

When placebos are NOT allowed

There's an ethical rule that governs placebo use in trials: you cannot withhold a proven, effective treatment from someone who needs it just to run a cleaner experiment. This is called the standard of care principle.

So in a trial for a condition where an effective treatment already exists, participants in the control group usually receive the existing standard treatment — not a placebo. The trial then compares the new treatment against what already works, not against nothing.

Placebos are most common in trials for conditions where no effective treatment currently exists, or in add-on studies where participants continue their existing treatment and receive either the investigational drug or placebo on top of it.

How to find out whether this trial uses a placebo

Check the consent form under "Study Design" or "Randomization." It will tell you whether the trial is placebo-controlled. It should also state the randomization ratio — for example, 2:1 means for every 2 participants receiving active treatment, 1 receives placebo.

You can also check the trial's entry on ClinicalTrials.gov. Under "Interventions" it will list both the investigational product and comparator, which will tell you what the control arm is receiving.

What "blinded" means for you

Most placebo-controlled trials are blinded — meaning you don't know whether you're receiving the active treatment or placebo, and often neither does the study team. This is called double-blinding. It's designed to prevent the expectations of participants and researchers from influencing the results.

If you're in a blinded trial and suspect you're receiving placebo because you're not experiencing any effects, don't try to find out by stopping your current medications or doing anything that could affect the study. If your suspicion is causing you real distress, talk to the study team. In some circumstances, unblinding is possible.

What happens if you receive a placebo and the treatment works

Many trials include provisions for crossover — if the treatment shows clear effectiveness during the study, participants who received placebo may be offered access to the active treatment. Ask the study team whether this applies to the trial you're considering. It's a legitimate and important question.